231 related articles for article (PubMed ID: 33796075)
1. Complications and Comorbidities of Acromegaly-Retrospective Study in Polish Center.
Rolla M; Jawiarczyk-Przybyłowska A; Halupczok-Żyła J; Kałużny M; Konopka BM; Błoniecka I; Zieliński G; Bolanowski M
Front Endocrinol (Lausanne); 2021; 12():642131. PubMed ID: 33796075
[TBL] [Abstract][Full Text] [Related]
2. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.
Gasperi M; Martino E; Manetti L; Arosio M; Porretti S; Faglia G; Mariotti S; Colao AM; Lombardi G; Baldelli R; Camanni F; Liuzzi A;
J Endocrinol Invest; 2002 Mar; 25(3):240-5. PubMed ID: 11936466
[TBL] [Abstract][Full Text] [Related]
4. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
Serri O; Beauregard C; Hardy J
J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
[TBL] [Abstract][Full Text] [Related]
5. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.
Carmichael JD; Bonert VS; Mirocha JM; Melmed S
J Clin Endocrinol Metab; 2009 Feb; 94(2):523-7. PubMed ID: 19033371
[TBL] [Abstract][Full Text] [Related]
6. [Acromegaly and it's cardiovascular implications].
Cadena-Obando DA; Remba-Shapiro I; Abreu-Rosario CG; Mercado M
Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):73-80. PubMed ID: 33667046
[TBL] [Abstract][Full Text] [Related]
7. Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism.
Bondanelli M; Bonadonna S; Ambrosio MR; Doga M; Gola M; Onofri A; Zatelli MC; Giustina A; degli Uberti EC
Metabolism; 2005 Sep; 54(9):1174-80. PubMed ID: 16125529
[TBL] [Abstract][Full Text] [Related]
8. Gender- and age-related differences in the endocrine parameters of acromegaly.
Colao A; Amato G; Pedroncelli AM; Baldelli R; Grottoli S; Gasco V; Petretta M; Carella C; Pagani G; Tambura G; Lombardi G
J Endocrinol Invest; 2002 Jun; 25(6):532-8. PubMed ID: 12109625
[TBL] [Abstract][Full Text] [Related]
9. Hormonal diagnosis of GH hypersecretory states.
Grottoli S; Gasco V; Ragazzoni F; Ghigo E
J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
[TBL] [Abstract][Full Text] [Related]
10. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
[TBL] [Abstract][Full Text] [Related]
11. Acromegaly.
Chanson P; Salenave S
Orphanet J Rare Dis; 2008 Jun; 3():17. PubMed ID: 18578866
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments.
Ronchi CL; Giavoli C; Ferrante E; Verrua E; Bergamaschi S; Ferrari DI; Corbetta S; Montefusco L; Arosio M; Ambrosi B; Spada A; Beck-Peccoz P
Eur J Endocrinol; 2009 Jul; 161(1):37-42. PubMed ID: 19351744
[TBL] [Abstract][Full Text] [Related]
13. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
[TBL] [Abstract][Full Text] [Related]
14. Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.
Cheng S; Al-Agha R; Araujo PB; Serri O; L Asa S; Ezzat S
PLoS One; 2013; 8(9):e73543. PubMed ID: 24039977
[TBL] [Abstract][Full Text] [Related]
15. Acromegaly among a Moroccan population.
Guerboub AA; Issouani J; Joumas KJ; Er Rahali Y
Pan Afr Med J; 2023; 46():116. PubMed ID: 38465009
[TBL] [Abstract][Full Text] [Related]
16. Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone.
Subbarayan SK; Fleseriu M; Gordon MB; Brzana JA; Kennedy L; Faiman C; Hatipoglu BA; Prayson RA; Delashaw JB; Weil RJ; Hamrahian AH
Endocr Pract; 2012; 18(6):817-25. PubMed ID: 22784832
[TBL] [Abstract][Full Text] [Related]
17. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
18. Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease.
Mercado M; Espinosa de los Monteros AL; Sosa E; Cheng S; Mendoza V; Hernández I; Sandoval C; Guinto G; Molina M
Horm Res; 2004; 62(6):293-9. PubMed ID: 15542931
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone/insulin-like growth factor I axis, glucose metabolism, and lypolisis but not leptin show some degree of refractoriness to short-term fasting in acromegaly.
Grottoli S; Gasco V; Mainolfi A; Beccuti G; Corneli G; Aimaretti G; Dieguez C; Casanueva F; Ghigo E
J Endocrinol Invest; 2008 Dec; 31(12):1103-9. PubMed ID: 19246978
[TBL] [Abstract][Full Text] [Related]
20. [Acromegaly].
Chanson P
Presse Med; 2009 Jan; 38(1):92-102. PubMed ID: 19004612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
